Acacia Research Corp ACTG announced today that a subsidiary has
acquired a patent for stent graft technology.
“Acacia continues to increase the number of patent portfolios we control
in the medical device and diagnostics sectors,” commented Paul Ryan,
CEO. “Acacia is expanding its presence as a leader in patent licensing
for both the technology and medical technology sectors.”
ABOUT ACACIA RESEARCH CORPORATION
Acacia Research Corporation's subsidiaries partner with inventors and
patent owners, license the patents to corporate users, and share the
revenue. Acacia Research Corporation's subsidiaries control over 200
patent portfolios, covering technologies used in a wide variety of
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in